Nathan P. Wirick, PharmD, BCPS

Nathan P. Wirick, PharmD, BCPS

Clinical Specialist Infectious Disease
Hillcrest Hospital Pharmacy Services
Cleveland Clinic Health System East Region
Phone: 440.312.8592
Fax: 440.312.7104
Pager: 216.464.8410 #50549
Email: nwirick@ccf.org

Clinical Specialist at Hillcrest since 2005.

Education/Experience
  • Bachelor of Arts in Biology and Chemistry minor 1998, Wittenberg University, Springfield, OH
  • Doctor of Pharmacy 2003, The Ohio State University, Columbus, OH
  • Pharmacy Practice Residency 2003 to 2004, MetroHealth Medical Center, Cleveland, OH
  • Infectious Disease Specialty Residency 2004 to 2005, The Ohio State University Medical Center, Columbus, OH
  • Clinical Specialist at Hillcrest Hospital since 2005
  • Lexi-Comp Consultant since 2008
  • Board Certificated Pharmacotherapy Specialist 2011 (BCPS)
Areas of interest
  • Infectious Disease
    • Antibiotic resistance, antifungal therapy, antimicrobial management
  • Daily clinical rounds with Infectious Disease physicians
Research / Current Projects
  • Antibiogram Review-Revision
  • Resistance Trends
  • Antimicrobial Agent Utilization
  • Renal Dosing Policy
  • Drug Stability
  • Quality Measures: Surgical Prophylaxis and Pneumonia
Service
  • Committee member for the following Hospital Performance Improvement Committees: Member of P & T Committee, Antimicrobial Sub-committee, Infection Control, Surgical Care Improvement Project Committee, Pneumonia Subcommittee, Anti-Microbial Stewardship Committee
Teaching
  • Preceptor for PGY1 Pharmacy Residents
  • Preceptor for PharmD students
  • Continuing education to nursing, pharmacy, and physicians at Hillcrest Hospital
  • Lecture at Ursuline College for Nurse Practitioners
Honors and Awards
  • Message to Garcia Award Winner 2005, The Ohio State University Medical Center Department of Pharmacy Award
Poster Presentations
  • Poster Presentation: December 2015 ASHP Mid-year Meeting, New Orleans, Louisiana. A review of ceftaroline fosamil utilization at a large community teaching hospital. Hillcrest Hospital, Mayfield Heights, OH.
  • Poster Presentation: December 2013 ASHP Mid-year Meeting, Orlando, Florida. Candida spp. Isolate review and impact on prescribing preferences in a community hospital. Hillcrest Hospital, Mayfield Heights, OH.
  • Poster Presentation: December 2012 ASHP Mid-year Meeting, Las Vegas. Impact of converting levofloxacin to high-dose equivalent regimen in a community teaching hospital. Hillcrest Hospital, Mayfield Heights, OH.
  • Co-Author Poster Presentation: September 2005 Fall Meeting IDSA San Francisco: Epidemiology of Infections in LVAD Patients. The Ohio State University Medical Center, Columbus, OH.
  • Poster Presentation: May 2005 MAD ID Spring Meeting, Arizona: Analysis of Empirical Use of Linezolid in a Large Teaching Hospital. The Ohio State University Medical Center, Columbus, OH.
  • Poster Presentation: April 2005 ACCP Spring Meeting, Myrtle Beach: Analysis of Empirical Use of Linezolid in a Large Teaching Hospital. The Ohio State University Medical Center, Columbus, OH.
  • Poster Presentation: December 2004 ASHP Mid-year Meeting, Orlando. Analysis of Linezolid Therapy for Staphylococcal or Enterococcal Infections at a Large Teaching Hospital. The Ohio State University Medical Center, Columbus, OH.
  • Poster Presentation: May 2004 OCCP Spring Meeting, Cleveland. Hepatotoxicity in Tuberculosis Patients. The MetroHealth Medical Center, Cleveland OH.
  • Poster Presentation: December 2003 New Orleans ASHP Mid-year Meeting: Hepatotoxicity in Tuberculosis Patients. The MetroHealth Medical Center, Cleveland OH.